Viewing Study NCT05066802


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-06-13 @ 10:32 PM
Study NCT ID: NCT05066802
Status: UNKNOWN
Last Update Posted: 2021-10-04
First Post: 2021-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma
Sponsor: Yonsei University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Resectable Pancreatic Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None resectable pancreatic cancer View
None Neoadjuvant View